REGARD PHASE 3, RANDOMIZED TRIAL OF RAMUCIRUMAB IN PATIENTS WITH METASTATIC GASTRIC OR GEJ ADENOCARCINOMA FOLLOWING PROGRESSION ON FIRST-LINE CHEMOTHERAPY

• Authors: TABERNERO Josep; TOMÁŠEK Jiří; FILIP Dumitru; PASSALACQUA Rodolfo
• Year of publication: 2013
• Type: Appeared in Conference without Proceedings